(Q33372365)

26 July 2017

title

Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome (English)

1 reference

26 July 2017

Howard Trachtman

4

0 references

author name string

Laura De Petris

series ordinal

1

1 reference

26 July 2017

Jilma Patrick

series ordinal

2

1 reference

26 July 2017

Erica Christen

series ordinal

3

1 reference

26 July 2017

publication date

1 January 2006

1 reference

26 July 2017

1 reference

26 July 2017

volume

28

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

475-482

1 reference

Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Cell cycle regulation and differentiation in the human podocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Podocytopenia and disease severity in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Podocyte loss and progressive glomerular injury in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220600778902

10.1080/08860220600778902

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference